Human papillomavirus type 16 E6 and NFX1-123 mislocalize immune signaling proteins and downregulate immune gene expression in keratinocytes
- PMID: 29117186
- PMCID: PMC5695606
- DOI: 10.1371/journal.pone.0187514
Human papillomavirus type 16 E6 and NFX1-123 mislocalize immune signaling proteins and downregulate immune gene expression in keratinocytes
Abstract
Human papillomavirus (HPV) is the most prevalent sexually transmitted infection, affecting an estimated 11% of the world's population. The high-risk HPV types (HR HPV) account for approximately 5% of the global burden of cancer and thus cause high morbidity and mortality. Although it is known that persistent infection with HR HPV is the greatest risk factor for developing HPV-associated cancer, and that the HPV early proteins E6 and E7 dysregulate immune detection by its host cells, the mechanisms of immune evasion by HR HPV are not well understood. Previous work in the laboratory identified the endogenous cytoplasmic host protein NFX1-123 as a binding partner of the HR HPV type 16 oncoprotein E6 (16E6). Together NFX1-123 and 16E6 affect cellular growth, differentiation, and immortalization genes and pathways. In a whole genome microarray, human foreskin keratinocytes (HFKs) stably expressing 16E6 and overexpressing NFX1-123 showed a diverse set of innate immune genes downregulated two-fold or more when compared to 16E6 cells with endogenous NFX1-123. We demonstrated that 16E6 and NFX1-123 decreased expression of pro-inflammatory cytokines and interferon-stimulated genes (ISGs) in 16E6 HFKs at the mRNA and protein level. Knock down of NFX1-123 in 16E6 HFKs resulted in a derepression of innate immune genes, pointing to the requirement of NFX1-123 for immune regulation in the context of 16E6. Studies using immunofluorescent microscopy revealed that 16E6 and NFX1-123 disturbed the normal localization of signaling proteins involved in initiating the immune response. This study identifies NFX1-123 as a critical host protein partner through which 16E6 is able to subvert the immune response and in turn permit a long-lived HR HPV infection.
Conflict of interest statement
Figures






Similar articles
-
NFX1-123 is highly expressed in cervical cancer and increases growth and telomerase activity in HPV 16E6 expressing cells.Cancer Lett. 2019 May 1;449:106-113. doi: 10.1016/j.canlet.2019.02.024. Epub 2019 Feb 16. Cancer Lett. 2019. PMID: 30776478 Free PMC article.
-
Human papillomavirus 16E6 and NFX1-123 potentiate Notch signaling and differentiation without activating cellular arrest.Virology. 2015 Apr;478:50-60. doi: 10.1016/j.virol.2015.02.002. Epub 2015 Feb 25. Virology. 2015. PMID: 25723053 Free PMC article.
-
NFX1-123 and human papillomavirus 16E6 increase Notch expression in keratinocytes.J Virol. 2013 Dec;87(24):13741-50. doi: 10.1128/JVI.02582-13. Epub 2013 Oct 9. J Virol. 2013. PMID: 24109236 Free PMC article.
-
Post-Transcriptional Gene Regulation by HPV 16E6 and Its Host Protein Partners.Viruses. 2022 Jul 6;14(7):1483. doi: 10.3390/v14071483. Viruses. 2022. PMID: 35891463 Free PMC article. Review.
-
Evasion of host immune defenses by human papillomavirus.Virus Res. 2017 Mar 2;231:21-33. doi: 10.1016/j.virusres.2016.11.023. Epub 2016 Nov 24. Virus Res. 2017. PMID: 27890631 Free PMC article. Review.
Cited by
-
Cervical Cancer Development: Implications of HPV16 E6E7-NFX1-123 Regulated Genes.Cancers (Basel). 2021 Dec 8;13(24):6182. doi: 10.3390/cancers13246182. Cancers (Basel). 2021. PMID: 34944802 Free PMC article.
-
Genes Regulated by HPV 16 E6 and High Expression of NFX1-123 in Cervical Cancers.Onco Targets Ther. 2020 Jun 26;13:6143-6156. doi: 10.2147/OTT.S251926. eCollection 2020. Onco Targets Ther. 2020. PMID: 32617009 Free PMC article.
-
NFX1-123: A potential therapeutic target in cervical cancer.J Med Virol. 2023 Jun;95(6):e28856. doi: 10.1002/jmv.28856. J Med Virol. 2023. PMID: 37288708 Free PMC article.
-
Human Papillomavirus 16 E5 Inhibits Interferon Signaling and Supports Episomal Viral Maintenance.J Virol. 2020 Jan 6;94(2):e01582-19. doi: 10.1128/JVI.01582-19. Print 2020 Jan 6. J Virol. 2020. PMID: 31666385 Free PMC article.
-
HPV E6/E7: insights into their regulatory role and mechanism in signaling pathways in HPV-associated tumor.Cancer Gene Ther. 2024 Jan;31(1):9-17. doi: 10.1038/s41417-023-00682-3. Epub 2023 Dec 15. Cancer Gene Ther. 2024. PMID: 38102462 Review.
References
-
- Doorbar J, Quint W, Banks L, Bravo IG, Stoler M, Broker TR, et al. (2012) The biology and life-cycle of human papillomaviruses. Vaccine 30: F55–F70. doi: 10.1016/j.vaccine.2012.06.083 - DOI - PubMed
-
- Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518–527. doi: 10.1056/NEJMoa021641 - DOI - PubMed
-
- Stratton KL, Culkin DJ (2016) A Contemporary Review of HPV and Penile Cancer. Oncology (Williston Park, NY) 30. - PubMed
-
- Kreimer AR, Clifford GM, Boyle P, Franceschi S (2005) Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 14: 467–475. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous